Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of Genetic Mutations on Response and Time to Progression after Radioembolization of Breast Cancer Liver Metastases.

Journal of vascular and interventional radiology : JVIR - 1 Jul 2026

Bajnauth Daana, Deipolyi Amy, Annie Frank, Bryce Yolanda

Abstract excerpt

PURPOSE: To evaluate the association between genetic mutations and clinical outcomes, including response and time to progression, in patients with breast cancer liver metastases treated with yttrium-90 (90Y) radioembolization. MATERIALS AND METHODS: A retrospective, single-institution study of 110 female patients with breast cancer liver metastases who underwent 90Y radioembolization and genomic profiling using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Erb-b2 Receptor Tyrosine Kinases

Share to Liver Neoplasms

Share to Radiopharmaceuticals

Share to Time Factors

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 42025916
DOI: 10.1016/j.jvir.2026.108819
PMCID: PMC13181361

Genes

CBFB
ERBB2
H3C13
IMPACT
KDM5C
RAD21
RUNX1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of Genetic Mutations on Response and Time to Progression after Radioembolization of Breast Cancer Liver Metastases.PMID 42025916Read ↗

Association of PI3K Pathway Mutations with Early Positron-Emission Tomography/CT Imaging Response after Radioembolization for Breast Cancer Liver Metastases: Results of a Single-Center Retrospective Pilot Study.Semantic proximity Read ↗

Frequency of genetic alterations differs in advanced breast cancer between metastatic sites.Semantic proximity Read ↗

PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases.Semantic proximity Read ↗

Targetable genomic profiling of breast cancer brain metastases identifies alterations and genomic signatures relevant to immune-checkpoint and PARP inhibitorsSemantic proximity Read ↗

Impact of Genomic Mutation and Timing of Y90 Radioembolization in Colorectal Liver Metastases.Semantic proximity Read ↗

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapySemantic proximity Read ↗

Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer.Semantic proximity Read ↗

Metastatic Breast Cancer to the Spine: Incidence of Somatic Gene Alterations and Association of Targeted Therapies With Overall Survival.Semantic proximity Read ↗

Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.Semantic proximity Read ↗

From Feasibility to Individualization: Surgery for Breast Cancer Liver and Lung MetastasesSemantic proximity Read ↗

Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancer.Semantic proximity Read ↗

The impact of CHEK2 status on radiosurgical outcomes in breast cancer brain metastases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.